SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

9807	Companies
196724	Keywords
127731	Articles
104589	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 12/24/2025 at 07:00, 1 month 12 days ago

Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Sanofi provides update on tolebrutinib regulatory submission for non-relapsing secondary progressive multiple sclerosis, with FDA issuing a complete response letter and further guidance expected in Q1 2026

FDA Multiple Sclerosis Sanofi Tolebrutinib Regulatory Submission
BRIEF

published on 12/23/2025 at 15:11, 1 month 12 days ago

Le Wayrilz de Sanofi obtient l'approbation de l'UE pour le traitement de la thrombocytopénie immunitaire

Sanofi Wayrilz Inhibiteur De BTK Thrombocytopénie Immunitaire Approbation De L'UE
BRIEF

published on 12/23/2025 at 15:11, 1 month 12 days ago

Sanofi's Wayrilz receives EU approval for the treatment of IPT

EU Sanofi TPI Wayrilz BTK
BRIEF

published on 12/23/2025 at 15:11, 1 month 12 days ago

Sanofi's Wayrilz Gets EU Approval for Treating Immune Thrombocytopenia

Sanofi EU Approval BTK Inhibitor Wayrilz Immune Thrombocytopenia
BRIEF

published on 12/23/2025 at 15:11, 1 month 12 days ago

Wayrilz de Sanofi reçoit l'approbation de l'UE pour le traitement de la TPI

EU Sanofi TPI Wayrilz BTK
PRESS RELEASE

published on 12/23/2025 at 15:06, 1 month 12 days ago

Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia
Sanofi's Wayrilz, a novel BTK inhibitor, approved in the EU for treating immune thrombocytopenia. Offers multi-immune modulation for ITP management

Sanofi BTK Inhibitor Wayrilz Immune Thrombocytopenia Multi-immune Modulation
PRESS RELEASE

published on 12/23/2025 at 15:06, 1 month 12 days ago

Communiqué de presse : Wayrilz de Sanofi approuvé dans l’UE comme premier inhibiteur de la BTK pour le traitement de la thrombocytopénie immunitaire (TPI)
Wayrilz de Sanofi approuvé dans l’UE comme premier inhibiteur de la BTK pour le traitement de la thrombocytopénie immunitaire (TPI). Nouvelle approche novatrice ciblant les causes sous-jacentes de la TPI

Traitement Wayrilz Thrombocytopénie Immunitaire BTK Inhibiteur
BRIEF

published on 12/23/2025 at 07:05, 1 month 13 days ago

Le Dupixent de Sanofi et Regeneron approuvé au Japon pour les enfants atteints d'asthme

Japon Sanofi Dupixent Regeneron Asthme Infantile
BRIEF

published on 12/23/2025 at 07:05, 1 month 13 days ago

Le Dupixent de Sanofi et Regeneron obtient l'autorisation de mise sur le marché au Japon pour les jeunes patients asthmatiques

Sanofi Dupixent Approbation Du Japon Regeneron Asthme
BRIEF

published on 12/23/2025 at 07:05, 1 month 13 days ago

Sanofi and Regeneron's Dupixent approved in Japan for children with asthma

Japan Sanofi Dupixent Regeneron Childhood Asthma

Accesswire

Published on 02/05/2026 at 09:05, 2 hours 24 minutes ago

BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
Published on 02/05/2026 at 01:35, 9 hours 54 minutes ago

Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 11 hours 29 minutes ago

Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 13 hours 4 minutes ago

55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 18:00, 17 hours 29 minutes ago

Lithium South AGSM Update

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 11:16, 13 minutes ago

FUCHS strengthens its presence in Türkiye with the complete takeover of the joint venture OPET FUCHS
Published on 02/05/2026 at 11:00, 29 minutes ago

CHANGES TO THE BOARD OF DIRECTORS
Published on 02/05/2026 at 10:48, 41 minutes ago

EQS-Adhoc: Evonik Industries AG: Executive Board adjusts dividend policy
Published on 02/05/2026 at 10:05, 1 hour 24 minutes ago

VT Markets Powers Reliable Gold Trading Amid Extreme Market Volatility
Published on 02/05/2026 at 10:05, 1 hour 24 minutes ago

Signing of strategic technology supply and offtake agreement with Carester, US$20 million equity investment from the Industrial Development Corporation, and commencement of DFS for the Zandkopsdrift magnet rare earths and battery grade manganese

Les Echos

Published on 02/04/2026 at 18:04, 17 hours 25 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 17 hours 25 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 17 hours 44 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 17 hours 44 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 02/04/2026 at 17:45, 17 hours 44 minutes ago

Janvier 2026

View all LES ECHOS COMFI WIRE